Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

UFS subscribes to ResearchResearch
2006-02-20

ResearchResearch is the world's leading publisher of news and information for the international research community. From their offices in London, Sydney, Washington, Brussels, Amsterdam and Sweden their editorial team provides unrivalled expertise and in-depth news coverage of research policy and politics, and comprehensive listings of funding opportunities and sponsors across all disciplines.

The information on this site is stored in three interlinked databases:
1. Funding opportunities
2. Sponsors
3. News

Funding opportunities
Records include a detailed abstract of the opportunity including details of eligibility requirements, deadline, the original text of the call (where available); and links to the application form, specific page of the sponsor's web site, contact details of programme management and records in our Sponsors database describing the relevant research programme and sponsor. Note: You will only see funding opportunities that you and your researchers are eligible to apply for.

The Funding opportunities database has been designed to be easy to use for occasional users but offers complex search options for regular users. Opportunities can be browsed by Sponsor, by discipline, type of sponsor, purpose of award, by deadline, eligibility, and so on.

Sponsors
Records include the objectives, eligibility requirements and application procedures of sponsors along with relevant links to the sponsors’ web pages. Note: You will only see sponsors that you and your researchers are eligible to apply for funding from.

News
Keep up to date with global research developments. Research Day Worldwide, a roundup of all the latest in research policy and politics from the UK, US, Europe, Australia & New Zealand, Asia and Africa.

Access to ResearchResearch.com is available from any PC on the university network, though staff is encouraged to obtain their own username and password, which allows access from a PC off the University network, as well as allowing staff to set up customised funding alerts on their own areas of research and subscribe to news alerts (click on Apply for a personal account under my institution's license to register and obtain a username and password).

Other facilities include the ability to bookmark information, collate and distribute it to colleagues in the form of a "Magazine". This is especially useful for staff with a research co-ordination role.
Further detail is available from the Directorate Research Development (Dr Aldo Stroebel, stroebea.rd@mail.uovs.ac.za, 401 3506).

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept